Attention Deficit Hyperactivity Disorder: Understanding a Common Neurodevelopmental Condition
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most prevalent childhood neurodevelopmental disorders. Characterized by difficulties with attention, hyperactivity, and impulsivity, ADHD can significantly impair functioning at school, home, and socially if left unaddressed (American Psychiatric Association, 2013). While still widely misunderstood, recent research has furthered understanding of ADHD’s causes, presentation, and most effective treatment approaches. This paper aims to provide an up-to-date overview of ADHD based on current literature.
Definition and Diagnosis
The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) defines ADHD as “a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development” (American Psychiatric Association, 2013, p. 59). To receive an ADHD diagnosis, a child must exhibit at least six symptoms of inattention and/or hyperactivity-impulsivity for at least six months to a degree that is disruptive and inappropriate for their developmental level. Symptoms must have been present before age 12 and occur in at least two settings such as home and school.
Common inattentive symptoms include difficulty sustaining attention, poor listening skills, disorganization, and avoidance of tasks requiring mental effort over time (American Psychiatric Association, 2013). Hyperactive-impulsive symptoms encompass excessive fidgeting or squirming, difficulty remaining seated, excessive talking, difficulty waiting one’s turn, and acting without thinking. For a diagnosis, symptoms must cause clinically significant impairment.
Prevalence and Risk Factors
Worldwide, ADHD prevalence among children is estimated at 5% according to a meta-analysis, with boys twice as likely as girls to receive a diagnosis (Thomas et al., 2015). Risk factors for ADHD development include prematurity, low birth weight, family history of ADHD, exposure to environmental toxins like lead, and socioeconomic disadvantage (Faraone et al., 2015). Genetics also play an important role, as ADHD tends to run in families (Faraone et al., 2018).
Neurobiology of ADHD
Neuroimaging research has found differences in brain structure and function between individuals with and without ADHD. The prefrontal cortex, involved in executive functions like attention, appears smaller in volume in ADHD (Faraone et al., 2018). During tasks, those with ADHD show less activity in prefrontal and parietal regions and more impulsive behavior correlated with striatal activity compared to controls (Hart et al., 2020). Dopamine and norepinephrine pathways implicated in reward and attention may also differ in those with ADHD (Del Campo et al., 2011). These neurobiological findings provide insight into ADHD’s underlying causes.
Impairments and Outcomes
Individuals with ADHD often face academic underachievement, low self-esteem, troubled peer and family relationships, and higher rates of accidental injury compared to peers without ADHD (Barbaresi et al., 2013; Weyandt et al., 2013). Up to 65% of children with ADHD may continue to experience impairing symptoms as adults according to a meta-analysis (Agnew-Blais et al., 2016). ADHD also increases the risk for co-occurring conditions like anxiety, depression, and substance abuse disorders (Bernardi et al., 2021). However, with proper treatment, individuals can learn to manage their symptoms and live fulfilling lives.
Treatment Approaches
Current treatment recommendations for ADHD involve medication management and psychosocial interventions (National Institute of Mental Health, 2020). Stimulant medications like methylphenidate and amphetamines that increase dopamine and norepinephrine levels are the most commonly prescribed ADHD treatments due to their effectiveness in reducing core symptoms (Daley et al., 2014). Behavioral therapies teach organizational skills, time management strategies, and coping mechanisms. Parents receive training on positive discipline techniques to apply consistency and structure.
Combined treatment addressing medication and lifestyle factors has been shown to most effectively help individuals with ADHD (Daley et al., 2014). Psychosocial interventions target skill-building and family/school support critical to ADHD management. Lifestyle modifications such as adequate sleep, nutritious diet, physical activity, and minimized screen time can also provide benefits (National Institute of Mental Health, 2020). With proper diagnosis and multi-modal treatment, individuals with ADHD can learn to succeed despite challenges.
In summary, ADHD is a common neurodevelopmental condition characterized by difficulties with attention, hyperactivity, and impulsivity. Recent research has furthered understanding of its causes in genes and brain function, impairments across settings, and most effective treatment approaches involving medication and behavior therapy. Proper diagnosis and management utilizing current treatment guidelines can help individuals with ADHD develop strategies to achieve their full potential at school, in relationships, and throughout life. With continued research, awareness of ADHD will expand and reduce stigma around what is a highly prevalent yet often misunderstood disorder.
Agnew-Blais, J. C., Polanczyk, G. V., Danese, A., Wertz, J., Moffitt, T. E., & Arseneault, L. (2016). Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA psychiatry, 73(7), 713–720.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Weaver, A. L., & Jacobsen, S. J. (2007). Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. Journal of developmental and behavioral pediatrics: JDBP, 28(4), 265–273.
Bernardi, S., Faraone, S. V., Cortese, S., Kerridge, B. T., Pallanti, S., Wang, S., & Blanco, C. (2021). Attention-deficit hyperactivity disorder comorbidities and impairments across the life span. Journal of clinical psychiatry, 82(3).
Daley, D., Van Der Oord, S., Ferrin, M., Danckaerts, M., Doepfner, M., Cortese, S., & Sonuga-Barke, E. J. (2014). Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. Journal of the American Academy of Child & Adolescent Psychiatry, 53(8), 835–847.
Del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological psychiatry, 69(12), e145–e157.
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J., Tannock, R., & Franke, B. (2015). Attention-deficit/hyperactivity disorder. Nature reviews. Disease primers, 1, 15020.
Faraone, S. V., Rostain, A. L., Blader, J., Busch, B., Childress, A. C., Connor, D. F., & Newcorn, J. H. (2018). Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder – implications for clinical recognition and treatment. Journal of child psychology and psychiatry, and allied disciplines, 59(11), 1152–1170.
Hart, H., Radua, J., Nakao, T., Mataix-Cols, D., & Rubia, K. (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA psychiatry, 70(2), 185–198.
National Institute of Mental Health. (2020, February). Attention Deficit Hyperactivity Disorder (ADHD).
Thomas, R

Published by
Write essays
View all posts